15.468 articles found

Intracellular peptide library screening to derive inhibitors of Parkinson's disease associated α-synuclein aggregation

Cheruvara H.

· 2015-01-01

The electrophysiological impact of oligomeric alpha-Synuclein on thick-tufted layer 5 pyramidal neurons in the neocortex of mice

Kaufmann TJ.

· 2015-01-01

Evaluating the relationship between alpha-synuclein phosphorylation and amyloid-beta in Lewy body diseases

Swirski MIH.

· 2015-01-01

The role of alpha-synuclein oligomers in Parkinson's disease pathophysiology and biology

Roberts RF.

· 2015-01-01

Alpha-synuclein in Parkinson's disease : molecular pathogenesis and development of genome engineering-based silencing approaches

Heman-Ackah SM.

· 2015-01-01

Modeling LRRK2 Pathobiology in Parkinson's Disease: From Yeast to Rodents.

Daniel G, Moore DJ.

Curr Top Behav Neurosci · 2015-01-01

DOI: 10.1007/7854_2014_311PMID: 24850078

I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.

Sieczkowski E, Milenkovic I, Venkataramani V, Giera R, Ströbel T, Höftberger R, Liberski PP, Auff E, Wirths O, Bayer TA, Kovacs GG.

J Alzheimers Dis · 2015-01-01

DOI: 10.3233/jad-141524PMID: 25182745

Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits.

Hatami A, Chesselet MF.

Curr Top Behav Neurosci · 2015-01-01

DOI: 10.1007/7854_2014_355PMID: 25218491

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.

Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Martínez J, Marti-Masso JF, Ferrer I, López de Munain A, Goldman SM, Schüle B, Langston JW, Aasly JO, Giordana MT, Bonifati V, Puschmann A, Canesi M, Pezzoli G, Maues De Paula A, Hasegawa K, Duyckaerts C, Brice A, Stoessl AJ, Marras C.

JAMA Neurol · 2015-01-01

DOI: 10.1001/jamaneurol.2014.2704PMID: 25401511

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

Agalliu I, San Luciano M, Mirelman A, Giladi N, Waro B, Aasly J, Inzelberg R, Hassin-Baer S, Friedman E, Ruiz-Martinez J, Marti-Masso JF, Orr-Urtreger A, Bressman S, Saunders-Pullman R.

JAMA Neurol · 2015-01-01

DOI: 10.1001/jamaneurol.2014.1973PMID: 25401981

Genetics of leprosy: expected and unexpected developments and perspectives.

Sauer ME, Salomão H, Ramos GB, D'Espindula HR, Rodrigues RS, Macedo WC, Sindeaux RH, Mira MT.

Clin Dermatol · 2015-01-01

DOI: 10.1016/j.clindermatol.2014.10.001PMID: 25432815

Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.

Allen Reish HE, Standaert DG.

J Parkinsons Dis · 2015-01-01

DOI: 10.3233/jpd-140491PMID: 25588354